Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MicroX Labs
Bloomfield Hills, Michigan, United Statesmicroxlabs.com ↗
- Ownership
- Private
- Employees
- ~7
- Development stage
- Preclinical
01
Overview
MicroX Labs has developed HomeCyte, a portable diagnostic device enabling rapid complete blood count and protein marker testing at the point of care or home. The technology leverages microfluidic impedance cytometry and machine learning to provide results in under 7–20 minutes. It is designed to improve cancer patient management by reducing hospital visits and infection risks[1][2][3][5].
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- DeviceDiagnostic device (microfluidics impedance cytometer)
- Industry
- Protein Biomarker Diagnostics
Beyond the preview
Go deeper on MicroX Labs.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MicroX Labs.